Active ingredients: encorafenib
What it is used for
Encorafenib in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, as detected by a validated test.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 30 degrees Celsius
- Store in Original Container
- Shelf lifetime is 18 Months.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Flesh-coloured opaque cap and white opaque body, printed with a stylised 'A' on the cap and 'LGX 75 mg' on the body. The length of the capsule is approximately 23 mm.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.